V. Ravery

5.1k citations
160 papers · 3.7k indexed · h-index 37

V. Ravery

146 papers receiving 3.5k citations

Peers

V. Ravery
Comparison fields: 5 of 115
  • Urology 543
  • Pulmonary and Respiratory Medicine 2.5k
  • Rheumatology 1.0k
  • Cancer Research 398
  • Surgery 1.1k
Replace L Boccon-Gibod with:
L Boccon-Gibod France
Angel M. Serio United States
Daniel B. Rukstalis United States
Hanjong Ahn South Korea
Farhang Rabbani United States
Marc Zerbib France
Giovanni Lughezzani Italy
Hendrik Isbarn Germany
David Schilling Germany
Dimitri Vordos France
V. Ravery relative to L Boccon-Gibod France L Boccon-Gibod's profile →
Citations per field
00.5×1.5×
L Boccon-Gibod · 1×
Citations per year

Countries citing papers authored by V. Ravery

Since Specialization
Citations

This map shows the geographic impact of V. Ravery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Ravery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Ravery more than expected).

Fields of papers citing papers by V. Ravery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Ravery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Ravery. The network helps show where V. Ravery may publish in the future.

Co-authorship network

The 25 scholars most cited alongside V. Ravery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with V. Ravery Line = papers co-authored together V. Ravery links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20188
2 20172
3 20133
4 201315
5 20111
6 201133
7 20108
8 200714
9 20072
10 20066
11 200272
12 20026
13 200173
14 20003
15 200067
16 19989
17 19984
18 199762
19 199717
20 199336

About V. Ravery

V. Ravery is a scholar working on Urology, Rheumatology, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Surgery, having authored 160 papers that have together received 3.7k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (87 papers), Prostate Cancer Treatment and Research (73 papers), Urologic and reproductive health conditions (40 papers), Bladder and Urothelial Cancer Treatments (29 papers), Urological Disorders and Treatments (20 papers), Urinary and Genital Oncology Studies (14 papers), Ureteral procedures and complications (12 papers) and Urinary Bladder and Prostate Research (12 papers). The work is most often cited by research in Urology (543 citations), Pulmonary and Respiratory Medicine (2.5k citations), Rheumatology (1.0k citations), Cancer Research (398 citations) and Surgery (1.1k citations). V. Ravery has collaborated with scholars based in France, Austria and Germany. Frequent co-authors include L Boccon-Gibod, M Toublanc, V. Delmas, L. Boccon‐Gibod, Bob Djavan, Michael Marberger, Michaël Peyromaure, Mesut Remzi, Jean‐François Hermieu and Axel Heidenreich. Their work appears in journals such as The Journal of Urology, European Urology, Urology, British Journal of Urology and Journal of Endourology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026